No Data
No Data
Bitcoin Climbs to Fresh High, Market Shifts into Climb | Wall Street Today
Merck Readies New Keytruda Version Ahead of Major Regulatory Headwinds
Incyte Pares Some Losses on Report of Potential Merck Takeover Interest
Express News | Merck Is the Latest Industry Giant to Be Linked to a Takeover Bid for Incyte- Sky News Reporter Mark Kleinman on X
J.P. Morgan Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $145
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
loading...